NCT06351995View on ClinicalTrials.gov

Neostigmine and Glycopyrrolate by Iontophoresis

PHASE3Active, not recruitingINTERVENTIONAL
Enrollment

6

Participants

Timeline

Start Date

November 6, 2020

Primary Completion Date

October 25, 2022

Study Completion Date

January 1, 2025

Conditions
Spinal Cord InjuriesConstipationFecal IncontinenceNeurogenic Bowel
Interventions
DRUG

Combination of Neostigmine and Glycopyrrolate

Intravenous or transdermal

DEVICE

I-Box by Dynatronics

Electric field conducting drugs through the skin without compromising its integrity

Trial Locations (1)

10468

James J. Peters Veterans Affairs Medical Center, The Bronx

All Listed Sponsors
lead

James J. Peters Veterans Affairs Medical Center

FED